Topics

New antibody treatment provides little relief for high-frequency migraine patients

20:00 EDT 9 Jul 2019 | AAAS

(Oregon Health & Science University) An early assessment reveals that the newly approved antibody treatment Erenumbab does not seem effective among patients who suffer from high-frequency migraines.

Original Article: New antibody treatment provides little relief for high-frequency migraine patients

NEXT ARTICLE

More From BioPortfolio on "New antibody treatment provides little relief for high-frequency migraine patients"

Quick Search

Relevant Topic

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...